Updated on 11 August 2015
BioClinica serves more than 400 pharmaceutical, biotechnology, and device organizations, worldwide
Singapore: With a view to further streamline its clinical trial operations and better serve customers, BioClinica, a specialty clinical trials services and technology provider, recently announced the launch of the BioClinica eHealth Cloud-a flexible and highly configurable platform that extends beyond the scope of traditional clinical trial technology approaches.
BioClinica's extensive and highly interoperable clinical trials platform, that includes Express EDC, Trident RTSM, Optimizer Supply Forecasting and Simulation, OnPoint CTMS and Compass "Intelligent" Risk-Based Monitoring solution, will be optimized for delivery through the eHealth Cloud.
BioClinica said that eHealth Cloud offers the right platform to meet the meet the specific needs of individual clinical trials and offers unlimited accessibility and a variety of delivery options to better meet the current and future needs of both preapproval and post approval research.
Mr Mukhtar Ahmed, BioClinica's president of eClinical Solutions, said, "The eHealth Cloud creates inherent flexibility, scalability and agility while maintaining the highest levels of quality and security. This represents a major leap forward in clinical trial sponsor empowerment whereby sponsors and CROs' can choose from cloud delivery options that better enable them to achieve their scientific and business objectives."
BioClinica is a specialty clinical trials services provider that improves the development of new medical therapies by delivering expertise and technologies that enhance clinical research data and analytics, worldwide. The company serves more than 400 pharmaceutical, biotechnology, and device organizations - including all of the top 20 - through a network of offices in the US, Europe and Asia.